lomustine and Myasthenia Gravis
lomustine has been researched along with Myasthenia Gravis in 1 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Nakamura, S | 1 |
| Kawaguchi, K | 1 |
| Fukui, T | 1 |
| Hakiri, S | 1 |
| Ozeki, N | 1 |
| Mori, S | 1 |
| Goto, M | 1 |
| Hashimoto, K | 1 |
| Ito, T | 1 |
| Yokoi, K | 1 |
Other Studies
1 other study available for lomustine and Myasthenia Gravis
| Article | Year |
|---|---|
Multimodality therapy for thymoma patients with pleural dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; | 2019 |